Staff Reports
The Associated Press published a sharp investigation alleging that Drug Enforcement Administration agents in New Mexico watched large shipments of counterfeit fentanyl pills reach the streets between 2023 and 2025 without seizing them. That report triggered an immediate response from the DEA itself and new calls for criminal and congressional probes. This is a story about choices — dangerous choices — and who will answer for them.
AP investigation: DEA monitored shipments instead of seizing them
The AP found that agents sometimes tracked deliveries of fentanyl pills instead of confiscating them so they could chase bigger targets higher up the chain. The reporting says one delivery of 74,000 pills was watched at an Albuquerque mobile-home park. Whistleblower DEA Special Agent David Howell told AP that agents on one multistate case allowed at least 1.8 million pills to be delivered without seizure. Howell’s blunt line: “We poisoned our community to make cases.” That is the heart of the new allegation, and it is chilling.
Scale, risk, and why this matters
Fentanyl is not a normal drug. Tiny amounts can kill. The AP notes that millions of counterfeit pills may have been allowed to circulate while investigators tried to reach higher-level traffickers. That decision is controversial because the public-health stakes are enormous. New Mexico has suffered rising overdose deaths, and local leaders say these tactics cost lives. The numbers make the controversy real, not theoretical.
DEA response and the new OIG review
After the AP story, DEA Administrator Terry Cole asked the Justice Department’s Office of Inspector General to review the operations in New Mexico. The DEA also argued the AP account mischaracterized lawful investigations. Still, the OIG review and growing pressure from New Mexico’s governor and congressional members mean those internal explanations will face outside scrutiny. If the agency truly balanced prosecutions against public safety, it should welcome that kind of daylight — unless it has something to hide.
Policy choices, accountability, and what comes next
The controversy didn’t arise in a vacuum. Justice Department guidance on fentanyl was rewritten in 2024 to give investigators more discretion about seizures. That policy change, paired with old “controlled delivery” tactics, looks like a recipe for tragedy when the product is a mass-casualty drug. Governor Michelle Lujan Grisham has demanded a criminal probe and asked the state attorney general to act. Congress and the OIG now have decisions to make: hold accountable the people who let pills hit the streets, or let bureaucratic logic stand in for justice. The families and communities harmed deserve more than explanations and press statements. They deserve answers and consequences.
